Hereditary prothrombotic conditions were routinely investigated in previous studies of neonatal APS, particularly mutations in the methylenetetrahydrofolate reductase C677T and prothrombin G20210A genes that could explain the low prevalence of these prothrombotic factors in most reported cases [16]. This evidence concerns the gene F2 and autoimmune polyendocrinopathy.